Spectrum Pharmaceuticals, Handok Pharmaceutical Co. Ltd. deal

Spectrum granted Handok South Korean rights to develop and commercialize apaziquone. The analog of mitomycin C that is reduced by intracellular reductase into active DNA-damaging moieties is in Phase ...